Aanwerving proef = ; Lopend onderzoek = ; Terminated trial = ; Gefinancierd door een IRDiRC-lid = ; Lid van een ERN =

Nationale klinische studie(s)

DUITSLAND

Bayern
MÜNCHEN

Efficacy, Safety, and Tolerability of Fosmetpantotenate (RE-024), a Phosphopantothenate replacement therapy, in patients with Pantothenate Kinase-associated Neurodegeneration (PKAN): A Randomized, Double-blind, Placebo-Controlled Study with an Open-Label Extension (Phase III) -DE-

Friedrich-Baur-Institut

Friedrich-Baur-Institut an der Neurologischen Klinik und Poliklinik

Meer details

Multinationale klinische studie(s)

USA

Washington
ADDRESS: NOT PROVIDED - US

Efficacy, Safety, and Tolerability of Fosmetpantotenate (RE-024), a Phosphopantothenate replacement therapy, in patients with Pantothenate Kinase-associated Neurodegeneration (PKAN): A Randomized, Double-blind, Placebo-Controlled Study with an Open-Label Extension

Institution: Information not provided - US

Meer details